Clinical Trial Update: A Study of Avutometinib for People With Solid Tumor Cancers [Phase 1]

View source ↗

Summary

A Phase 1 study of Avutometinib for people with solid tumors, including CNS tumors and NF1-associated tumors, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor
• Low-grade Glioma
• Neuroblastoma
• Neurofibromatosis Type
• Optic Pathway Glioma
• Plexiform Neurofibroma
• Solid Tumor

Drugs mentioned

• Avutometinib (avutometinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Refractory Cancer, CNS Tumors | Phase 1 | Status: RECRUITING